(Q36268446)

13 August 2017

1 reference

title

AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa (English)

1 reference

AIDS-related Kaposi's sarcoma

13 August 2017

0 references

0 references

1 reference

1 reference

2

Philippe Mayaud

1 reference

13 August 2017

Gerhard Sissolak

1

0 references

language of work or name

1 reference

1 October 2005

1 reference

Tropical Medicine and International Health

13 August 2017

1 reference

13 August 2017

10

1 reference

13 August 2017

10

1 reference

13 August 2017

981-992

1 reference

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Aids-related malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Idiopathisches multiples Pigmentsarkom der Haut

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Management of Kaposi sarcoma: the role of interferon and thalidomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Successful treatment of cutaneous Kaposi's sarcoma by the 585-nm pulsed dye laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Sexual transmission and the natural history of human herpesvirus 8 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Mucosal shedding of human herpesvirus 8 in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

21 January 2018

KSHV (HHV8) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Antibodies against human herpesvirus 8 in black South African patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Tumor and infection localization in AIDS patients: Ga-67 and Tl-201 findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01491.X

10.1111/J.1365-3156.2005.01491.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16185232